|
[1]Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B:a 2015 update[J].J Clin Hepatol,2015,31(12):1941-1960.(in Chinese)中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2015年更新版)[J].临床肝胆病杂志,2015,31(12):1941-1960.
|
|
[2]Drug-induced Liver Disease Study Group,Chinese Society of Hepatology,Chinese Medical Association.Guidelines for the management of drug-induced liver injury[J].J Clin Hepatol,2015,31(11):1752-1769.(in Chinese)中华医学会肝病学分会药物性肝病学组.药物性肝损伤诊治指南[J].临床肝胆病杂志,2015,31(11):1752-1769.
|
|
[3]HAN T,LIU Y,LIU H,et al.Serum thymosin beta4 levels in patients with hepatitis B virus-related liver failure[J].World J Gastroenterol,2010,16(5):625-630.
|
|
[4]LI Z,SU SP,SUN JM.Safety and efficacy of thymosinα1 treatment of patients with chronic severe hepatitis B[J].China Prac Med,2013,8(14):63-64.(in Chinese)李峥,苏双萍,孙家敏.胸腺肽α1治疗慢性乙型重型肝炎的临床疗效观察[J].中国实用医药,2013,8(14):63-64.
|
|
[5]CHAVEZ-TAPIA NC,MENDIOLA-PASTRANA I,ORNELASARROYO VJ,et al.Granulocyte-colony stimulating factor for acuteon-chronic liver failure:systematic review and meta-analysis[J].Ann Hepatol,2015,14(5):631-641.
|
|
[6]SPAHR L,LAMBERT JF,RUBBIA-BRANDT L,et al.Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis:a randomized trial[J].Hepatology,2008,48(1):221-229.
|
|
[7]SINGH V,SHARMA AK,NARASIMHAN RL,et al.Granulocyte colony-stimulating factor in severe alcoholic hepatitis:a randomized pilot study[J].Am J Gastroenterol,2014,109(9):1417-1423.
|
|
[8]GARG V,GARG HK,KHAN A,et al.Granulocyte-colony stimulating factor mobilizes CD34+cells and improves survival of patients with acute-on-chronic liver failure[J].Gastroenterology,2012,142(3):505-512.
|
|
[9]DUAN XZ,LIU FF,TONG JJ,et al.Granulocyte-colony stimulating factor therapy improves survival in patients with hepatitis B virus-associated acute-on-chronic liver failure[J].World J Gastroenterol,2013,19(7):1104-1110.
|
|
[10]SINGH T,GUPTA N,ALKHOURI N,et al.A guide to managing acute liver failure[J].Cleve Clin J Med,2016,83(6):453-462.
|
|
[11]BAJAJ JS,RATLIFF SM,HEUMAN DM,et al.Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis[J].Aliment Pharmacol Ther,2012,36(9):866-874.
|
|
[12]AMODIO P,BEMEUR C,BUTTERWORTH R,et al.The nutritional management of hepatic encephalopathy in patients with cirrhosis:International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus[J].Hepatology,2013,58(1):325-336.
|
|
[13]Chinese Society of Gastroenterology,Chinese Medical Association;Chinese Society of Hepatology,Chinese Medical Association.Consensus statement on the diagnosis and treatment of hepatic encephalopathy in China(2013,Chongqing)[J/CD].Chin J Front Med Sci:Electronic Version,2014,6(2):81-93.(in Chinese)中华医学会消化病学分会,中华医学会肝病学分会.中国肝性脑病诊治共识意见(2013年,重庆)[J/CD].中国医学前沿杂志:电子版,2014,6(2):81-93.
|
|
[14]VILSTRUP H,AMODIO P,BAJAJ J,et al.Hepatic encephalopathy in chronic liver disease:2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver[J].Hepatology,2014,60(2):715-735.
|
|
[15]EGEROD ISRAELSEN M,GLUUD LL,BENDTSEN F,et al.Hepatorenal syndrome:diagnosis,treatment and prevention[J].Ugeskr Laeger,2013,175(22):1562-1566.
|
|
[16]PIANO S,MORANDO F,FASOLATO S,et al.Continuous recurrence of type 1 hepatorenal syndrome and long-term treatment with terlipressin and albumin:a new exception to MELD score in the allocation system to liver transplantation?[J].J Hepatol,2011,55(2):491-496.
|
|
[17]GLUUD LL,CHRISTENSEN K,CHRISTENSEN E,et al.Terlipressin for hepatorenal syndrome[J].Cochrane Database Syst Rev,2012,12(9):CD005162.
|
|
[18]ZHANG Y,NIE QH.Analysis of complications and death causes of1892 patients with liver failure[J].J Pract Hepatol,2014,17(2):129-132.(in Chinese)张野,聂青和.1892例肝衰竭患者并发症及死亡原因分析[J].实用肝脏病杂志,2014,17(2):129-132.
|
|
[19]LI L,NING GX,SUN MH,et al.Effects of multi disciplinary team management model on the short-term prognosis of patients with liver failure[J].Chin J Med Guide,2016,18(2):211-212.(in Chinese)李力,宁更献,孙梅花,等.多学科团队管理模式对肝功能衰竭患者近期预后的影响[J].中国医药导刊,2016,18(2):211-212.
|
|
[20]CHEN JJ,HUANG JR,YANG Q,et al.Plasma exchange-centered artificial liver support system in hepatitis B virus-related acute-on-chronic liver failure:a nationwide prospective multicenter study in China[J].Hepatobiliary Pancreat Dis Int,2016,15(3):275-281.
|
|
[21]SCHILSKY ML.Acute liver failure and liver assist devices[J].Transplant Proc,2011,43(3):879-883.
|
|
[22]NYBERG SL.Bridging the gap:advances in artificial liver support[J].Liver Transpl,2012,18(Suppl 2):s10-s14.
|
|
[23]XU X,LIU X,LING Q,et al.Artificial liver support system combined with liver transplantation in the treatment of patients with acute-onchronic liver failure[J].PLoS One,2013,8(3):e58738.
|
|
[24] Liver Failure and Artificial Liver Group,Guideline for non-bioartificial liver support systems in treatment of liver failure:2016 update[J].Chin J Clin Infect Dis,2016,9(2):97-103.(in Chinese)中华医学会感染病学分会肝衰竭与人工肝学组.非生物型人工肝治疗肝衰竭指南(2016)[J].中华临床感染病杂志,2016,9(2):97-103.
|
|
[25]LI J,ZHANG L,XIN J,et al.Immediate intraportal transplantation of human bone marrow mesenchymal stem cells prevents death from fulminant hepatic failure in pigs[J].Hepatology,2012,56(3):1044-1052.
|
|
[26]STARZL TE.The long reach of liver transplantation[J].Nat Med,2012,18(10):1489-1492.
|
|
[27]ZHENG SS,YU J,ZHANG W.Current development of liver transplantation in China[J].J Clin Hepatol,2014,30(1):2-4.(in Chinese)郑树森,俞军,张武.肝移植在中国的发展现状[J].临床肝胆病杂志,2014,30(1):2-4.
|
DownLoad: